CoCites: A citation-based method for searching scientific literature

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.

Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff, Walter Heindel, Maximilian Reiser, Hans H Schild. J Clin Oncol 2010
Times Cited: 272

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.

Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione, Sandro Morassut, Cosimo Di Maggio, Anna Cilotti, Laura Martincich, Massimo Calabrese, Chiara Zuiani, Lorenzo Preda, Bernardo Bonanni, Luca A Carbonaro, Alma Contegiacomo, Pietro Panizza, Ernesto Di Cesare, Antonella Savarese, Marcello Crecco, Daniela Turchetti, Maura Tonutti, Paolo Belli, Alessandro Del Maschio. Invest Radiol 2011
Times Cited: 196

List of shared articles

Times cited

Cost-effectiveness analysis in radiology: methods, results and implications.
Matthias F Froelich, Wolfgang G Kunz, Fabian Tollens, Moritz L Schnitzer, Stefan O Schönberg, Clemens G Kaiser, Johannes Rübenthaler. Rofo 2022

Breast Cancer Conspicuity on Computed Versus Acquired High b-Value Diffusion-Weighted MRI.
Michaela R DelPriore, Debosmita Biswas, Daniel S Hippe, Mladen Zecevic, Sana Parsian, John R Scheel, Habib Rahbar, Savannah C Partridge. Acad Radiol 2021

Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
Matthias F Froelich, Clemens G Kaiser. Eur Radiol 2021

Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
Natsuko Onishi, Masako Kataoka. Breast Cancer 2021

Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Weibo Gao, Shuqun Zhang, Jinxia Guo, Xiaocheng Wei, Xiaohui Li, Yan Diao, Wei Huang, Yue Yao, Ali Shang, Yanyan Zhang,[...]. J Magn Reson Imaging 2021

Cost-effectiveness of MR-mammography vs. conventional mammography in screening patients at intermediate risk of breast cancer - A model-based economic evaluation.
Clemens G Kaiser, Matthias Dietzel, Tibor Vag, Matthias F Froelich. Eur J Radiol 2021

Supplemental Screening for Patients at Intermediate and High Risk for Breast Cancer.
Lilian Wang, Roberta M Strigel. Radiol Clin North Am 2021

Magnetic Resonance Imaging in Screening of Breast Cancer.
Yiming Gao, Beatriu Reig, Laura Heacock, Debbie L Bennett, Samantha L Heller, Linda Moy. Radiol Clin North Am 2021

Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program.
Matthew Castelo, Zachary Brown, Angela E Schellenberg, Jane K Mills, Andrea Eisen, Derek Muradali, Eva Grunfeld, Adena S Scheer. Breast J 2021

Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound.
Clemens G Kaiser, Matthias Dietzel, Tibor Vag, Johannes Rübenthaler, Matthias F Froelich, Fabian Tollens. Eur J Radiol 2021

Image quality and diagnostic value of diffusion-weighted breast magnetic resonance imaging: Comparison of acquired and computed images.
Hye Shin Ahn, Sung Hun Kim, Ji Youn Kim, Chang Suk Park, Robert Grimm, Yohan Son. PLoS One 2021

Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?
Fabian Tollens, Pascal A T Baltzer, Matthias Dietzel, Johannes Rübenthaler, Matthias F Froelich, Clemens G Kaiser. Cancers (Basel) 2021

Breast cancer.
Sibylle Loibl, Philip Poortmans, Monica Morrow, Carsten Denkert, Giuseppe Curigliano. Lancet 2021

Characterizing Errors in Pharmacokinetic Parameters from Analyzing Quantitative Abbreviated DCE-MRI Data in Breast Cancer.
Kalina P Slavkova, Julie C DiCarlo, Anum S Kazerouni, John Virostko, Anna G Sorace, Debra Patt, Boone Goodgame, Thomas E Yankeelov. Tomography 2021

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations.
Tamara Hettipathirana, Courtney Macdonald, Jing Xie, Kate Moodie, Chris Michael, Kelly-Anne Phillips. Med J Aust 2021

Enhancing social support and knowledge perception decreases patient delay in breast cancer.
Baisen Li, Li Xia, Jing Yang, Min Wen, Miao Yu, Exian Mou, Shiwei Liu, Hui Li, Hao Wang. Gland Surg 2021

Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening.
Fabian Tollens, Pascal A T Baltzer, Matthias Dietzel, Moritz L Schnitzer, Wolfgang G Kunz, Johann Rink, Johannes Rübenthaler, Matthias F Froelich, Clemens G Kaiser. Front Oncol 2021

MRI versus Mammography plus Ultrasound in Women at Intermediate Breast Cancer Risk: Study Design and Protocol of the MRIB Multicenter, Randomized, Controlled Trial.
Luigina Ada Bonelli, Massimo Calabrese, Paolo Belli, Stefano Corcione, Claudio Losio, Stefania Montemezzi, Federica Pediconi, Antonella Petrillo, Chiara Zuiani, Lucia Camera,[...]. Diagnostics (Basel) 2021

The Value of Tyrer-Cuzick Versus Gail Risk Modeling in Predicting Benefit from Screening MRI in Breast Cancer.
Anthanasios Sevdalis, Xiaoyan Deng, Dipankar Bandyopadhyay, Kandace P McGuire. Eur J Breast Health 2021

Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Anna M Chiarelli, Kristina M Blackmore, Derek Muradali, Susan J Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea Eisen, Linda Rabeneck, Ellen Warner. J Natl Cancer Inst 2020

Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
Francesco Sardanelli, Andrea Cozzi, Rubina Manuela Trimboli, Simone Schiaffino. AJR Am J Roentgenol 2020

Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection.
Anna Rotili, Rubina Manuela Trimboli, Silvia Penco, Filippo Pesapane, Priyan Tantrige, Enrico Cassano, Francesco Sardanelli. Breast Cancer Res Treat 2020

Screening in patients with increased risk of breast cancer (part 1): pros and cons of MRI screening.
S Alonso Roca, A B Delgado Laguna, J Arantzeta Lexarreta, B Cajal Campo, S Santamaría Jareño. Radiologia (Engl Ed) 2020

Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study.
Francesco Sardanelli, Rubina M Trimboli, Nehmat Houssami, Fiona J Gilbert, Thomas H Helbich, Marina Alvarez Benito, Corinne Balleyguier, Massimo Bazzocchi, Peter Bult, Massimo Calabrese,[...]. Eur Radiol 2020

Screening in patients with increased risk of breast cancer (part 2). Where are we now? Actual MRI screening controversies.
S Alonso Roca, A B Delgado Laguna, J Arantzeta Lexarreta, B Cajal Campo, A López Ruiz. Radiologia (Engl Ed) 2020

Percentage volume of delayed kinetics in computer-aided diagnosis of MRI of the breast to reduce false-positive results and unnecessary biopsies.
T Ha, D K Kang, T H Kim. Clin Radiol 2020

Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Paola Clauser, Matthias Dietzel, Michael Weber, Clemens G Kaiser, Pascal At Baltzer. Acta Radiol 2019

Comparison of the Diagnostic Performance of Synthetic Versus Acquired High b-Value (1500 s/mm² ) Diffusion-Weighted MRI in Women With Breast Cancers.
Jung Hyun Park, Bo La Yun, Mijung Jang, Hye Shin Ahn, Sun Mi Kim, Soo Hyun Lee, Eunyoung Kang, Eun-Kyu Kim, So Yeon Park. J Magn Reson Imaging 2019

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.
Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, Kristen Whitaker, Toshio F Yoshimatsu, Tom Walsh, David Schacht, Kirti Kulkarni, Deepa Sheth, Marion S Verp,[...]. Clin Cancer Res 2019

Summarizing the 4D image stack of ultrafast dynamic contrast enhancement MRI of breast cancer in 3D using color intensity projections.
Keith S Cover, Katya M Duvivier, Pim de Graaf, Rianne Wittenberg, Ruth Smit, Joost P A Kuijer, Mark B M Hofman, Ben J Slotman, Ruud M Verdaasdonk. J Magn Reson Imaging 2019

Abbreviated MRI Protocols in Breast Cancer Diagnostics.
Katerina Deike-Hofmann, Franziska Koenig, Daniel Paech, Constantin Dreher, Stefan Delorme, Heinz-Peter Schlemmer, Sebastian Bickelhaupt. J Magn Reson Imaging 2019

Abbreviated protocol breast MRI: The past, present, and future.
Heather I Greenwood. Clin Imaging 2019

Artificial Intelligence for Breast MRI in 2008-2018: A Systematic Mapping Review.
Marina Codari, Simone Schiaffino, Francesco Sardanelli, Rubina Manuela Trimboli. AJR Am J Roentgenol 2019

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).
Habib Rahbar, Zheng Zhang, Thomas L Chenevert, Justin Romanoff, Averi E Kitsch, Lucy G Hanna, Sara M Harvey, Linda Moy, Wendy B DeMartini, Basak Dogan,[...]. Clin Cancer Res 2019

Contrast-enhanced MRI for breast cancer screening.
Ritse M Mann, Christiane K Kuhl, Linda Moy. J Magn Reson Imaging 2019

Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: Rationale, Concept, and Transfer to Clinical Practice.
Christiane K Kuhl. Annu Rev Med 2019

Breast MRI ordering practices in a large health care network.
Ann L Brown, Jordana Phillips, Tejas S Mehta, Alexander Brook, Richard E Sharpe, Priscilla J Slanetz, Vandana Dialani. Breast J 2019